Abstract
Minimally invasive methodology, mathematical model, and software for analysis of glucose homeostasis by deconvolution of insulin secretion, hepatic extraction, post-hepatic delivery, and sensitivity from 24-hour standardized meals test have been developed and illustrated by the study of glucose homeostasis of a genetically based leptin-deficient patient before and after leptin replacement treatment. The only genetically leptin-deficient adult man identified in the world was treated for 24 months with recombinant methionyl human leptin. Blood was collected every 7 minutes for 24 hours, with standardized meals consumed during the 4 visits: at baseline, one-week, 18-months, and 24-months after initiation of the treatment. Concentrations of insulin, C-peptide, and plasma glucose were measured. Insulin secretion was obtained by deconvolution of C-peptide data. Hepatic insulin extraction was determined based on our modifications of the insulin kinetics model. Insulin sensitivity for each of the four meals was calculated by using the minimal glucose model approach. Hepatic extraction of insulin was the first element of glucose homeostasis to respond to leptin replacement treatment and increased 2-fold after one week of treatment. Insulin secretion and delivery rates decreased more than 2-fold and insulin sensitivity increased 10-fold after 24 months of treatment. Computer programs for analysis of 24-hour insulin secretion, extraction, delivery, and action are available upon request.
Key words
mathematical modeling - C-peptide - hepatic extraction - insulin action
References
1
Friedman JM.
Obesity in the new millennium.
Nature.
2000;
404
632-634
2
Lamounier-Zepter V, Ehrhart-Bornstein M, Bornstein SR.
Metabolic syndrome and the endocrine stress system.
Horm Metab Res.
2006;
38
437-441
3
Yudkin JS.
Inflammation, obesity and the metabolic syndrome.
Horm Metab Res.
2007;
39
707-709
4
Reimann M, Schutte AE, Schwarz PEH.
Insulin resistance – the role of ethnicity: evidence from Caucasian and African cohorts.
Horm Metab Res.
2007;
39
853-857
5
Fischer-Posovsky , Wabitsch M, Hochberg Z.
Endocrinology of adipose tissue. An update.
Horm Metab Res.
2007;
39
314-321
6
Guevara R, Valle A, Gianotti M, Roca P, Oliver J.
Gender-dependent differences in serum profiles of insulin and leptin in caloric restricted rats.
Horm Metab Res.
2008;
40
38-43
7 Toffolo GM, Cobelli C. Insulin modelling. In: Carson E, Cobelli C, eds. Modelling methodology for physiology and medicine . San Diego: Academic Press 2001: 305-335
8 Caumo A, Simeoni M, Cobelli C. Glucose modeling. In: Carson E, Cobelli C, eds. Modelling methodology for physiology and medicine . San Diego: Academic Press 2001: 337-372
9
Mari A.
Mathematical modeling in glucose metabolism and insulin secretion.
Curr Opin Clin Nutr Metab Care.
2002;
5
495-501
10
Mari A, Nielsen LL, Nanayakkara N, DeFronzo RA, Ferrannini E, Halseth A.
Mathematical modeling shows exanatide improved beta-cell functions in patients with type 2 diabetes treated with metformin or metformin and sulfonylurea.
Horm Metab Res.
2006;
38
838-844
11
Makroglou A, Li J, Kuang Y.
Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview.
App Num Math.
2006;
56
559-573
12
Caumo A, Bergman RN, Cobelli C.
Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index.
J Clin Endocrinol Metab.
2000;
85
4396-4402
13
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM.
Positional cloning of the mouse obese gene and its human homologue.
Nature.
1994;
372
425-432
14
Ceddia RB, Koistinen HA, Zierath JR, Sweeney G.
Analysis of paradoxical observations on the association between leptin and insulin resistance.
FASEB J.
2002;
16
1163-1176
15
Licinio J, Caglayan S, Ozata M, Yildiz BO, Miranda PB de, O’Kirwan F, Whitby R, Liang L, Cohen P, Bhasin S, Krauss RM, Veldhuis JD, Wagner AJ, DePaoli AM, MacCann SM, Wong M-L.
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults.
Proc Natl Acad Sci USA.
2004;
101
4531-4536
16
Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J.
Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.
J Clin Endocrinol Metab.
1980;
51
520-528
17
Toffolo G, Bergman RN, Finegood DT, Bowden CR, Cobelli C.
Quantitative estimation of beta cell sensitivity to glucose in the intact organism. A minimal model of insulin kinetics in the dog.
Diabetes.
1980;
29
979-990
18
Polonsky KS, Given BD, Pugh W, Licinio-Paixao J, Thompson JE, Karrison T, Rubenstein AH.
Calculation of systemic delivery rate of insulin in normal man.
J Clin Endocrinol Metab.
1986;
63
113-118
19
Cauter E van, Mestrez F, Sturis J, Polonsky KS.
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.
Diabetes.
1992;
41
368-377
20
Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B.
Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
J Clin Invest.
1986;
77
98-105
21
Vicini P, Caumo A, Cobelli C.
The hot IVGTT two-compartment minimal model: index of glucose effectiveness and insulin sensitivity.
Am J Physiol Endocrinol Metab.
1997;
273
1024-1032
22
Man CD, Caumo A, Basu R, Rizza R, Toggolo G, Cobelli C.
Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method.
Am J Physiol Endocrinol Metab.
2004;
287
E637-E643
23
Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG.
Effects of leptin on insulin sensitivity in normal rats.
Endocrinology.
1997;
138
3395-3401
24
Chinookoswong N, Wang JL, Shi ZQ.
Leptin restores euglycemia and normalizes glucose turnover in insulin deficient diabetes in the rat.
Diabetes.
1999;
48
1487-1492
25
Muzzin P, Eisensmith RC, Copeland KC, Woo SL.
Correction of obesity and diabetes in genetically obese mice by leptin gene therapy.
Proc Natl Acad Sci USA.
1996;
93
14804-14808
26
Cohen B, Novick D, Rubinstein M.
Modulation of insulin activities by leptin.
Science.
1996;
274
1185-1188
27
Muller G, Ertl J, Gerl M, Preibisch G.
Leptin impairs metabolic actions of insulin in isolated rat adipocytes.
J Biol Chem.
1997;
272
10585-10593
28
Sweeney G, Keen J, Somwar R, Konrad D, Garg R, Klip A.
High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting GLUT4 translocation in L6 rat skeletal muscle cells.
Endocrinology.
2001;
142
4806-4812
29
Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB.
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.
Nature.
2002;
415
339-343
30
Minokoshi Y, Kahn BB.
Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle.
Biochem Soc Trans.
2003;
31
196-201
31
Ceddia RB, William
Jr
WN, Curi R.
Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation.
Int J Obes Relat Metab Disord.
1999;
23
75-82
32
Harris RB.
Acute and chronic effects of leptin on glucose utilization in lean mice.
Biochem Biophys Res Commun.
1998;
245
502-509
33
Berti L, Kellerer M, Capp E, Haring HU.
Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect.
Diabetologia.
1997;
40
606-609
34
Bates SH, Gardiner JV, Jones RB, Bloom SR, Bailey CJ.
Acute stimulation of glucose uptake by leptin in L6 muscle cells.
Horm Metab Res.
2002;
34
111-115
35
Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ.
Acute stimulation of glucose metabolism in mice by leptin treatment.
Nature.
1997;
389
374-377
36
Ceddia RB.
Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis.
Int J Obesity.
2005;
29
1175-1183
37
Pliquett RU, Fuhrer D, Falk S, Zysset S, Cramon DY von, Stumvoll M.
The effects of insulin on the central nervous system- focus on appetite regulation.
Horm Metab Res.
2006;
38
442-446
38
Lee JH, Chan JL, Sourlas E, Raptopoulos V, Mantzoros CS.
r-metHuLeptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy (HAART).
J Clin Endocrinol Metab.
2006;
91
2605-2611
39
Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A.
Leptin-replacement therapy for lipodystrophy.
N Engl J Med.
2002;
346
570-578
40
Shapiro A, Matheny M, Zhang Y, Tumer N, Cheng K-Y, Rogrigues E, Zolotukhin S, Scarpace PJ.
Synergy between leptin therapy and a seemingly negligible amount of voluntary wheel running prevents progression of dietary obesity in leptin-resistant rats.
Diabetes.
2008;
57
614-622
41
Oliveira E, Fagundes ATS, Alves SB, Pazos-Moura CC, Moura EG, Passos MCF, Lisboa PC.
Chronic leptin treatment inhibits liver mitochondrial α-glycerol-β-phosphate dehydrogenase in euthyroid rats.
Horm Metab Res.
2007;
39
867-870
Clinical trial registry number: NCT00657605
Correspondence
J. LicinioMD
Miller Professor and Chairman
Department of Psychiatry & Behavioral Sciences (D-28)
University of Miami Miller School of Medicine
1120 NW 14th St, Suite 1455
Miami
33136 Florida
USA
Telefon: +1/305/243 26 76
Fax: +1/305/243 27 67
eMail: licinio@miami.edu